Selective serotonin reuptake inhibitor toxicity: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
==Clinical Features== | ==Clinical Features== | ||
* | *[[Nausea and vomiting]] | ||
*Sedation | *Sedation | ||
*Tremor | *Tremor | ||
*Sinus | *[[Sinus tachycardia]] | ||
*QRS, QT prolongation (citalopram only) | *QRS, [[QT prolongation]] (citalopram only) | ||
*[[Serotonin | *[[Serotonin syndrome]] | ||
==Differential Diagnosis== | |||
*[[Serotonin syndrome]] | |||
{{Anticholinergic types}} | |||
==Treatment== | ==Treatment== |
Revision as of 03:24, 16 December 2014
Background
- Most serious adverse effect is potential to produce Serotonin Syndrome
- Fatalities are uncommon with pure overdoses
Clinical Features
- Nausea and vomiting
- Sedation
- Tremor
- Sinus tachycardia
- QRS, QT prolongation (citalopram only)
- Serotonin syndrome
Differential Diagnosis
Anticholinergic toxicity Causes
- Medications[1]
- Atropine
- Antihistamines
- Antidepressants
- Antipsychotics
- Muscle relaxants
- Anti-Parkinsonians
- Plants
- Jimson weed (Devil's trumpet)
- Amanita mushroom
Treatment
- GI decontamination
- Activated charcoal x1
- Gastric lavage unnecessary
Disposition
- Consider admission for patients who are tachycardic or lethargic 6hr after ingesion
See Also
Source
Tintinalli
- ↑ Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium – theory, evidence and practice. Br J Clin Pharmacol. 2015;81(3):516-24.